- Report
- September 2022
- 67 Pages
Global
- Report
- September 2022
- 62 Pages
Global
From €4373EUR$4,950USD£3,831GBP
- Report
- August 2024
- 202 Pages
Global
From €2208EUR$2,500USD£1,935GBP
- Report
- December 2024
- 180 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- September 2024
- 183 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- May 2024
- 182 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- October 2023
- 175 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- October 2023
- 90 Pages
Japan
From €3092EUR$3,500USD£2,709GBP
- Report
- July 2024
- 120 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- January 2024
- 200 Pages
Global
From €3666EUR$4,150USD£3,212GBP
- Report
- February 2024
- 118 Pages
Global
From €4196EUR$4,750USD£3,676GBP
- Report
- August 2024
- 117 Pages
Middle East, Africa
From €3048EUR$3,450USD£2,670GBP
- Report
- August 2024
- 127 Pages
North America
From €3048EUR$3,450USD£2,670GBP
- Report
- April 2024
- 114 Pages
Global
From €3489EUR$3,950USD£3,057GBP
- Report
- April 2024
- 140 Pages
Global
From €3489EUR$3,950USD£3,057GBP
- Report
- April 2023
- 147 Pages
Global
From €4372EUR$4,949USD£3,830GBP
- Report
- September 2024
- 331 Pages
Asia Pacific
From €3268EUR$3,699USD£2,863GBP
- Report
- January 2024
- 150 Pages
Global
From €3401EUR$3,850USD£2,980GBP
€4284EUR$4,850USD£3,754GBP
- Report
- May 2023
- 150 Pages
Global
From €3401EUR$3,850USD£2,980GBP
€4284EUR$4,850USD£3,754GBP
- Report
- November 2023
- 439 Pages
Global
From €3180EUR$3,600USD£2,786GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more